AOD-9604

AOD-9604 is a small fragment of human growth hormone. It's built to copy just the fat-breakdown part of growth hormone, without triggering growth-related effects.

It interests researchers studying fat-cell biology — how stored fat gets released, and whether that signal can be separated from growth effects.

Cell and animal studies showed fat-cell activity without raising blood sugar or triggering growth pathways. Human evidence for any benefit is limited and not established.

Distinguishes established clinical findings from early human trials, animal experiments, or laboratory cell culture findings. No human dosing, injection instructions, or treatment recommendations are provided.

AOD-9604 is not FDA-approved as a medicine. It holds a 'generally recognized as safe' food-related status for a narrow research context only.

BBOHC LABS research reagents are non-clinical materials. An FDA approval for a finished medicine containing the same active ingredient does not imply that BBOHC's investigational research vial is FDA-approved.

Low-toxicity profile in cell studies. Handle per standard biosafety procedures.

• Heffernan M et al. Effects of human GH fragment AOD9604 on lipid metabolism. Endocrinology. 2001.

Specific citations are provided for literature context. Product purity & lot verification documentation available on request.